Washington, DC Bids > Bid Detail

The Future of Multiomic Analytical Instruments for Systems Biology

Agency:
Level of Government: Federal
Category:
  • A - Research and development
Opps ID: NBD00159963777558282
Posted Date: Dec 13, 2023
Due Date: Jan 12, 2024
Source: https://sam.gov/opp/f98c918e41...
Follow
The Future of Multiomic Analytical Instruments for Systems Biology
Active
Contract Opportunity
Notice ID
IARPA-RFI-24-01
Related Notice
Department/Ind. Agency
OFFICE OF THE DIRECTOR OF NATIONAL INTELLIGENCE
Sub-tier
INTELLIGENCE ADVANCED RESEARCH PROJECTS ACTIVITY
Office
IARPA CONTRACTING OFFICE
General Information
  • Contract Opportunity Type: Special Notice (Original)
  • All Dates/Times are: (UTC-05:00) EASTERN STANDARD TIME, NEW YORK, USA
  • Original Published Date: Dec 13, 2023 02:24 pm EST
  • Original Response Date: Jan 12, 2024 05:00 pm EST
  • Inactive Policy: 15 days after response date
  • Original Inactive Date: Jan 27, 2024
  • Initiative:
    • None
Classification
  • Original Set Aside:
  • Product Service Code: AJ12 - General Science and Technology R&D Services; General science and technology; Applied Research
  • NAICS Code:
    • 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
  • Place of Performance:
    Washington , DC 20511
    USA
Description

IARPA is seeking information on the current state of the art (SOTA) and future direction of analytical instruments capable of detecting, identifying, and characterizing the multitude of biomolecules that constitute or are associated with biological systems and materials. Such molecules include but are not limited to the macromolecules of carbohydrates (saccharides or sugars), nucleic acids (DNA and RNA, canonical and non-canonical), proteins (amino acids, peptides, and fully functional protein or proteins), and lipids (fatty acids) as well as metabolites, other small molecules, and inorganic metals. This RFI is issued for planning purposes only and does not constitute a formal solicitation for proposals or suggest the procurement of any material, data sets, etc.



IARPA recognizes and encourages the investments other entities are pursuing for improving single ‘omic’ or analyte characterization, especially focused on enabling improved single molecule sequencing of distinct analytes. IARPA’s mission is distinct from these entities with the mission to pursue even higher risk, higher impact activities and this RFI reflects IARPA’s interest in understanding what possible future capabilities may be achieved within a challenging concept space.



IARPA seeks to understand potential future concepts and multi-analyte extensible instruments/analytical platforms able to detect, identify, and/or characterize the range of biomolecules and other elements associated with biological systems and materials. IARPA’s interests align with single modality, analyte extensible, platforms or instruments which can conceivably be integrated into a single workflow matching or exceeding current SOTA capabilities. Critically, IARPA seeks to understand what advances can be achieved with (i) incremental improvements to current capabilities and (ii) with investments towards higher-risk, further afield research which have not been proven.



Responses to this RFI are due no later than 5:00 p.m. 12 January 2024, Eastern Time. All submissions must be electronically submitted as a PDF document. Inquiries and submissions to this RFI must be submitted to DNI-IARPA-RFI-24-01@iarpa.gov. Do not send questions with proprietary content. No telephone inquiries will be accepted.


Attachments/Links
Contact Information
Contracting Office Address
  • ODNI IARPA
  • Washington , DC 20511
  • USA
Primary Point of Contact
Secondary Point of Contact


History
  • Dec 13, 2023 02:24 pm ESTSpecial Notice (Original)

TRY FOR FREE

Not a USAOPPS Member Yet?

Get unlimited access to thousands of active local, state and federal government bids and awards in All 50 States.

Start Free Trial Today >